Thumbnail Image
Publication

Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

Lamb, Christopher A
; 
PREPARE-IBD, Study Group
Abstract
Tags * SARS-CoV-2
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2021
Type
Article
Subject
COVID-19
 Inflammatory bowel diseases
 United Kingdom
 SARS-CoV-2
Collections
NUH Nursing and Midwifery Registered
Show all metadata
Files
Thumbnail Image
Letter. risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.pdf
Adobe PDF, 438.99 KB
Citation
Lamb, C.A., Sebastian, S., Kent, A.J., Segal, J.P., Gonzalez, H.A., Brookes, M.J., Mehta, S.J., Subramanian, S., Bhala, N., Hicks, L.C., Conley, T.E., Patel, K.V., Walker, G.J., Kennedy, N.A. and PREPARE-IBD, S.G. (2021) 'Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study', Alimentary Pharmacology & Therapeutics, 53(11), pp. 1236-1240. https://pubmed.ncbi.nlm.nih.gov/33961708/
Journal / Source Title
DOI
URI
https://mider.dspace7.openrepository.com/handle/20.500.12904/15972
PMID
Publisher
John Wiley and Sons Ltd
Publisher’s URL
Publisher’s statement
Note / Copyright